Risk, Respect for Persons, and Informed Consent in Comparative Effectiveness Research

American Journal of Bioethics

Volumn 13, Issue 12, 2013, Pages 46-48

  Spellecy, Ryan ^a   Leuthner, Steven ^a   Farrell, Michael ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; ETHICS; HEALTH CARE QUALITY; HUMAN; HUMAN RELATION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; PERSONNEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT;

DISCLOSURE; HUMANS; INFORMED CONSENT; PHYSICIAN-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH PERSONNEL; RESEARCH SUBJECTS; RESEARCHER-SUBJECT RELATIONS; STANDARD OF CARE;

EID: 84889652053     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2013.851299     Document Type: Article

References (2)

1. May, T., Craig, J. M. and Spellecy, R. 2007. Viewpoint: IRBs, hospital ethics committees, and the need for "translational informed consent. Academic Medicine, 82 (7): 670-674.
2. Wendler, D. 2013. What should be disclosed to research participants?. American Journal of Bioethics, 13 (12): 3-8.